EUVIMEDEUVIMED entdecken
Open Access

Improving the Sensitivity-Specificity Balance of Human Papillomavirus Testing on Self- and Clinician-Collected Samples in South Africa

Gbenankpon M Houvessou, Rakiya Saidu, Rosalind Boa, Nomonde Mbatani iD, Jennifer Moodley iD, Louise Kuhn iD

JCO Global Oncology · 2025

DOI: 10.1200/go-25-00037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2025. Verfasst von Gbenankpon M Houvessou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Specimen Handling, Papillomaviridae. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute (NCI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Human papillomavirus (HPV) testing on self-collected samples may increase coverage of cervical cancer screening, but previous studies have observed lower specificity of HPV testing in self- versus clinician-collected samples. Here we investigate strategies to improve the sensitivity-specificity balance of a round of HPV testing on self-collected samples. MATERIALS AND METHODS Women living with and without HIV, age 30-65 years, were recruited in South Africa. Self-collected vaginal samples and clinician-collected cervical samples were tested with Xpert HPV, an assay that detects the 14 high-risk HPV types in five separate channels: (P1) HPV 16; (P2) HPV 18, 45; (P3) HPV 31, 33, 35, 52, 58; (P4) HPV 51, 59; and (P5) HPV 39, 56, 66, 68. All women underwent colposcopy with histology sampling, and diagnosis of cervical intraepithelial neoplasia grade 2 or greater (CIN2+) was determined by adjudicated pathology. The AUC and related performance parameters were calculated using logistic regression with the cycle threshold (Ct) values of the channels as predictors. RESULTS HPV prevalence in women without and with HIV was higher in self-collected (25.1% v 61.5%) than in clinician-collected samples (16.2% v 48.4%). The optimal model to predict CIN2+ used Ct values from the three channels that detect HPV 16, 18, 45, 31, 33, 35, 52, and/or 58. AUC was superior for testing on clinician-collected (0.908) than on self-collected samples (0.878; P = .0261) in women without HIV, as well as for women living with HIV (0.868 v 0.819; clinician v self; P = .0002). Alternate approaches to handling multiple types and sequential testing approaches did not allow self-testing to achieve equivalent performance to testing on clinician-collected samples. CONCLUSION Using more stringent Ct cutoffs on the three channels that detect the eight highest-risk HPV types can improve the sensitivity-specificity balance of a round of screening in both self- and clinician-collected samples. Although performance of HPV testing on self-collected samples is excellent, performance parameters are better on clinician-collected samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsUterine Cervical NeoplasmsSpecimen HandlingPapillomaviridaeUterine Cervical DysplasiaHumansFemaleSouth AfricaAdultMiddle AgedSensitivity and SpecificityAgedEarly Detection of CancerVaginal SmearsHuman Papillomavirus Viruses

Autor:innen und Institutionen

  • Gertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY.
  • Department Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Department Obstetrics and Gynaecology, Faculty of Health Sciences, South African Medical Research Council Gynaecology Cancer Research Centre, University of Cape Town, Cape Town, South Africa.
  • Faculty of Health Sciences, Cancer Research Initiative and School of Public Health, University of Cape Town, Cape Town, South Africa.
  • Department Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY.

ORCID-Profile: Nomonde Mbatani, Jennifer Moodley, Louise Kuhn

Förderung

  • NCI NIH HHS
  • National Cancer Institute (NCI)

Zitieren

APA

Houvessou, G. M., Saidu, R., Boa, R., Mbatani, N., Moodley, J., & Kuhn, L. (2025). Improving the Sensitivity-Specificity Balance of Human Papillomavirus Testing on Self- and Clinician-Collected Samples in South Africa. JCO Global Oncology. https://doi.org/10.1200/go-25-00037

Vancouver

Houvessou GM, Saidu R, Boa R, Mbatani N, Moodley J, Kuhn L. Improving the Sensitivity-Specificity Balance of Human Papillomavirus Testing on Self- and Clinician-Collected Samples in South Africa. JCO Global Oncology. 2025. doi:10.1200/go-25-00037

BibTeX
@article{Houvessou2025,
  author = {Houvessou, Gbenankpon M and Saidu, Rakiya and Boa, Rosalind and Mbatani, Nomonde and Moodley, Jennifer and Kuhn, Louise},
  title = {Improving the Sensitivity-Specificity Balance of Human Papillomavirus Testing on Self- and Clinician-Collected Samples in South Africa},
  journal = {JCO Global Oncology},
  year = {2025},
  doi = {10.1200/go-25-00037}
}
Kostenlos starten →